Novozymes albumin attracts two ‘top 10’ pharmas
Novozymes Biopharma has confirmed that two “top 10” pharmaceutical firms are using its modified human albumin in their drug development programmes.
Archives for February 4, 2014
UDG slims down services business into single unit
Pharmaceutical services provider UDG Healthcare (formerly United Drug) announced today the integration of its sales, marketing and medical service divisions into one group, named Ashfield.
UK’s MHRA updates risk-based site inspection strategies
The UK’s drug regulator is overhauling the way it manages its pharmaceutical manufacturer inspections to deal with its growing burden of site visits.
Ergomed partners with Ferrer to develop new insomnia drug
CRO Ergomed Clinical Research has partnered with Ferrer to support a Phase IIa study of the insomnia drug Lorediplon.
Johnson Matthey's controlled API biz sees positive Q3 sales after restructure
Johnson Matthey's decision to restructure its narcotic API business in light of increased UK competition has paid off, the company says.